[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-353660-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-353660-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","kntc1-initiates-a-kntc1e2f8myc-positive-feedback-loop-to-facilitate-tumorigenesis-and-enhance-chemoresistance-in-bladder-cancer","KNTC1 initiates a KNTC1/E2F8/MYC positive feedback loop to facilitate tumorigenesis and enhance chemoresistance in bladder cancer","","Background: Bladder cancer (BLCA) is a lethal malignancy often limited by chemoresistance and inadequate therapeutic options. Kinetochore-associated 1 (KNTC1) has been linked to cancer, but its regulatory role, mechanism, and treatment potential in BLCA were unclear. Methods combined public databases (TCGA, GEO) with clinical specimens and functional in vitro/in vivo assays, plus transcriptomic and binding/interaction studies. Results show KNTC1 upregulation promotes proliferation, invasion, metastasis, and gemcitabine resistance via an E2F8/MYC positive feedback axis driving PI3K/AKT/mTOR. Silencing KNTC1, especially with a MYC inhibitor and with PAE@shKNTC1 nanodelivery, mitigated chemoresistance and metastasis. Conclusion identifies a prognostic biomarker and therapeutic target for BLCA.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/kntc1-initiates-a-kntc1e2f8myc-positive-feedback-loop-to-facilitate-tumorigenesis-and-enhance-chemoresistance-in-bladder-cancer/353660/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/kntc1-initiates-a-kntc1e2f8myc-positive-feedback-loop-to-facilitate-tumorigenesis-and-enhance-chemoresistance-in-bladder-cancer/353660.png","ImageObject",300,407,{"name":42,"@type":43},"Noah","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does KNTC1 play in bladder cancer progression?","Question",{"text":63,"@type":64},"KNTC1 is significantly upregulated in BLCA and promotes cell proliferation, invasion, metastasis, and gemcitabine resistance. High expression correlates with poor patient prognosis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does KNTC1 regulate the E2F8/MYC signaling axis?",{"text":68,"@type":64},"KNTC1 binds E2F8 and facilitates its nuclear translocation, enhancing E2F8-mediated transcriptional activation of MYC. MYC then upregulates KNTC1, forming a positive feedback loop.",{"name":70,"@type":61,"acceptedAnswer":71},"How does KNTC1 inhibition affect chemoresistance and metastasis?",{"text":72,"@type":64},"Silencing KNTC1, particularly combined with a MYC inhibitor (10058-F4), overcomes gemcitabine resistance in vitro and in vivo. Targeted delivery of KNTC1 siRNA using PAE@shKNTC1 suppresses lung metastasis in a preclinical model.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},353660,1790918285,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},8796095462418,"https://ap-avatar.wpscdn.com/avatar/80000253c1241d02b47?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778826106357471780","Chen et al. Journal of Experimental & Clinical Cancer Research (2026) 45:38 [https://doi.org/10.1186/s13046-026-03651-4](https://doi.org/10.1186/s13046-026-03651-4)  \nJournal of Experimental & Clinical Cancer Research  \nRESEARCH Open Access  \nKNTC1 initiates a KNTC1/E2F8/MYC positive feedback loop to facilitate tumorigenesis and enhance chemoresistance in bladder cancer  \nKailai Chen1,2†, Hecheng Su1,2†, Feng Pei1,2†, Xi Chen1,2, Meiqi Xu1,2, Fang Chai3* and Yakun Luo 1,2*  \nAbstract  \nBackground Bladder cancer (BLCA) is a lethal malignancy frequently challenged by chemoresistance and limited therapeutic options. Kinetochore-associated 1 (KNTC1) has been implicated in cancer, yet its precise role, regulatory mechanism, and therapeutic potential in BLCA remain largely unexplored.  \nMethods We analyzed KNTC1 expression and its clinical relevance using public databases (TCGA, GEO) and clinical specimens. Functional roles of KNTC1 in proliferation, invasion, metastasis, and gemcitabine resistance were assessed through in vitro and in vivo experiments (CCK-8, transwell, xenograft models) . Mechanistic insights were gained via RNA-seq, co-immunoprecipitation, chromatin immunoprecipitation (ChIP), and luciferase reporter assays. A poly  \n(ß-amino ester) (PAE)-based nanoparticle was synthesized for targeted in vivo delivery of KNTC1 siRNA.  \nResults KNTC1 was significantly upregulated in BLCA tissues, and its high expression correlated with poor patient prognosis. Functionally, KNTC1 promoted BLCA cell proliferation, invasion, metastasis, and gemcitabine resistance. Mechanistically, KNTC1 bound to the transcription factor E2F8 and facilitated its nuclear translocation, thereby enhancing E2F8-mediated transcriptional activation of MYC. MYC, in turn, transcriptionally upregulated KNTC1, forming a positive feedback loop that drove hyperactivation of the oncogenic PI3K/AKT/mTOR pathway. Silencing KNTC1, especially in combination with a MYC inhibitor (10058-F4), overcame gemcitabine resistance in vitro and in vivo. Therapeutic delivery of KNTC1 siRNA via a novel PAE nanocarrier (PAE@shKNTC1) significantly suppressed lung metastasis in a preclinical model.  \nConclusion Our study identifies a novel KNTC1/E2F8/MYC positive feedback axis that drives BLCA tumorigenesis and chemoresistance. KNTC1 serves as both a prognostic biomarker and a promising therapeutic target, with targeted inhibition offering a potential novel strategy for BLCA treatment.  \n†Kailai Chen, Hecheng Su and Feng Pei contributed equally to this work.  \n*Correspondence:  \nFang Chai [fangchai@gmail.com](fangchai@gmail.com)[ ](fangchai@gmail.com)Yakun Luo [luoyankun@hrbmu.edu.cn](luoyankun@hrbmu.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/. The)[. The](http://creativecommons.org/licenses/by/4.0/. The)[ ](http://creativecommons.org/licenses/by/4.0/. The)Creative Commons Public Domain Dedication waiver ([http://creativecommons.org/publicdomain/zero/1.0/](http://creativecommons.org/publicdomain/zero/1.0/)) applies to the data made available in","cbCaifiE3gHGITYx","https://ap.wps.com/l/cbCaifiE3gHGITYx","pdf",17266821,23,"English","# Abstract\n# Background\n# Methods\n## Public database analysis\n## Functional experiments\n## Mechanistic assays\n# Results\n# Conclusion\n# Keywords","[{\"question\":\"What role does KNTC1 play in bladder cancer progression?\",\"answer\":\"KNTC1 is significantly upregulated in BLCA and promotes cell proliferation, invasion, metastasis, and gemcitabine resistance. High expression correlates with poor patient prognosis.\"},{\"question\":\"How does KNTC1 regulate the E2F8/MYC signaling axis?\",\"answer\":\"KNTC1 binds E2F8 and facilitates its nuclear translocation, enhancing E2F8-mediated transcriptional activation of MYC. MYC then upregulates KNTC1, forming a positive feedback loop.\"},{\"question\":\"How does KNTC1 inhibition affect chemoresistance and metastasis?\",\"answer\":\"Silencing KNTC1, particularly combined with a MYC inhibitor (10058-F4), overcomes gemcitabine resistance in vitro and in vivo. Targeted delivery of KNTC1 siRNA using PAE@shKNTC1 suppresses lung metastasis in a preclinical model.\"}]","KNTC1 initiates a KNTC1/E2F8/MYC positive feedback loop to facilitate tumorigenesis and enhance chemoresistance in bladder cancer | PDF",1790106588,58,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1e27a455792fca1bc522ba2bf43ceae1.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d94a5a0c33270195ba4c8c2819295f38.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/db718b28b937c8fb7e788cbcad76dd25.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7665519b8a52a3bf5828577e09342314.webp",980,1306]